Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
TerrAscend Corp.
SIC 0100 · Agricultural Production-Crops
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
TerrAscend Corp.
SIC 0100 · Agricultural Production-Crops
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
TerrAscend Corp.
SIC 0100 · Agricultural Production-Crops
Support
about
terms
$
TSNDF
TerrAscend Corp.
CIK:
0001778129
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Statement of Comprehensive Income [Abstract]
Revenue, net
$ 67,119
$ 65,006
$ 132,658
$ 129,309
Cost of sales
30,869
31,771
61,806
61,393
Gross profit
36,250
33,235
70,852
67,916
Operating expenses:
General and administrative
22,852
20,980
44,349
42,129
Amortization and depreciation
1,285
1,284
2,833
2,573
Other operating (income) expense
36
Total operating expenses
24,137
22,264
47,218
44,702
Income from operations
12,113
10,971
23,634
23,214
Other expense (income)
Finance and other expenses
8,810
8,747
18,135
17,082
Unrealized and realized (gain) loss on investments
271
(7)
271
735
Loss (gain) on fair value of derivative liabilities
1,171
(279)
(232)
(376)
Loss from revaluation of contingent consideration
(34)
0
346
Unrealized and realized foreign exchange loss (gain)
333
(648)
511
(607)
Income from continuing operations before provision for income taxes
1,528
3,192
4,949
6,034
Provision for income taxes
11,587
9,598
21,837
20,105
Net loss from continuing operations
(10,059)
(6,406)
(16,888)
(14,071)
Discontinued operations:
Income (loss) from discontinued operations, net of tax
2,004
(41,701)
828
(46,305)
Net loss
(8,055)
(48,107)
(16,060)
(60,376)
Foreign currency translation adjustment
(317)
854
(619)
840
Comprehensive loss
(7,738)
(48,961)
(15,441)
(61,216)
Net loss from continuing operations attributable to:
Common and proportionate Shareholders of the Company
(11,165)
(7,684)
(19,050)
(16,651)
Non-controlling interests
1,106
1,278
2,162
2,580
Comprehensive loss attributable to:
Common and proportionate Shareholders of the Company
(8,844)
(50,239)
(17,603)
(63,796)
Non-controlling interests
$ 1,106
$ 1,278
$ 2,162
$ 2,580
Net (loss) income per share - basic & diluted:
Continuing operations, basic
$ (0.04)
$ (0.03)
$ (0.06)
$ (0.06)
Continuing operations, diluted
(0.04)
(0.03)
(0.06)
(0.06)
Discontinued operations, basic
0.01
(0.14)
(0.16)
Discontinued operations, diluted
0.01
(0.14)
(0.16)
Net loss per share - basic
(0.03)
(0.17)
(0.06)
(0.22)
Net loss per share - diluted
$ (0.03)
$ (0.17)
$ (0.06)
$ (0.22)
Weighted average number of outstanding common shares, basic
309,364,563
299,087,022
308,950,479
296,137,440
Weighted average number of outstanding common shares, diluted
309,364,563
299,087,022
308,950,479
296,137,440
v3.26.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities
Net loss from continuing operations
$ (16,888)
$ (14,071)
Adjustments to reconcile net loss to net cash provided by operating activities
Accretion and accrued interest
4,946
4,306
Depreciation of property and equipment and amortization of intangible assets
8,021
7,729
Amortization of operating right-of-use assets
730
805
Share-based compensation
1,714
2,293
Deferred income tax expense
484
597
Gain on fair value of derivative liabilities
(232)
(376)
Unrealized and realized loss on investments
271
735
Loss from revaluation of contingent consideration
0
346
Provision for expected credit loss
826
673
Unrealized and realized foreign exchange loss (gain)
511
(607)
Impairment and other
36
(5)
Changes in operating assets and liabilities
Receivables
(262)
(511)
Inventory
(5,128)
4,580
Accounts payable and accrued liabilities
2,218
(5,046)
Income taxes paid and tax related liabilities
20,439
16,862
Prepaid expense and other current assets
(1,322)
79
Other assets and liabilities
(327)
90
Net cash provided by operating activities - continuing operations
16,037
18,479
Net cash used in operating activities - discontinued operations
(971)
(7,658)
Net cash provided by operating activities
15,066
10,821
Investing activities
Investment in property and equipment
(2,504)
(4,650)
Investment in note receivable, net of interest received
103
123
Investment in intangible assets
(44)
(726)
Cash portion of consideration paid in acquisition, net of cash received
(3,722)
(5,128)
Refund of deposit for business acquisition
3,400
0
Deposits for business acquisition
(250)
0
Net cash used in investing activities - continuing operations
(3,017)
(10,381)
Net cash provided by (used in) investing activities - discontinued operations
1,293
(737)
Net cash used in investing activities
(1,724)
(11,118)
Financing activities
Proceeds from loan payable, net of transaction costs
0
5,000
Loan principal paid, including exit fees
(16,236)
(1,966)
Capital distributions paid to non-controlling interests
(2,563)
(1,988)
Payment for contingent consideration
0
(386)
Proceeds from convertible debentures, net of issuance costs
18,967
0
Convertible debentures principal paid
(8,630)
0
Proceeds from exercise of stock options
20
0
Repurchases of common shares
(391)
(377)
Net cash (used in) provided by financing activities - continuing operations
(8,833)
283
Net cash used in financing activities- discontinued operations
(200)
0
Net cash (used in) provided by financing activities
(9,033)
283
Net increase (decrease) in cash and cash equivalents and restricted cash during the period
4,309
(14)
Net effects of foreign exchange
193
(191)
Cash and cash equivalents and restricted cash, beginning of the period
37,524
26,987
Cash and cash equivalents and restricted cash, end of the period
42,026
26,782
Supplemental disclosure with respect to cash flows
Cash (received) paid for income tax, net
(103)
4,501
Interest paid
17,081
13,266
Non-cash transactions
Note receivable issued as a noncontrolling interest contribution
1,681
Change in accrued capital expenditures
1,869
2,115
MARYLAND
Supplemental disclosure with respect to cash flows
Cash (received) paid for income tax, net
2,132
Federal income tax
Supplemental disclosure with respect to cash flows
Cash (received) paid for income tax, net
(3,790)
2,794
State income tax | NEW JERSEY
Supplemental disclosure with respect to cash flows
Cash (received) paid for income tax, net
1,521
1,606
State income tax | MARYLAND
Supplemental disclosure with respect to cash flows
Cash (received) paid for income tax, net
61
State income tax | Other
Supplemental disclosure with respect to cash flows
Cash (received) paid for income tax, net
$ 34
$ 40
v3.26.1
Unaudited Interim Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets
Cash and cash equivalents
$ 42,026
$ 37,414
Restricted cash
0
110
Accounts receivable, net
16,323
16,898
Investments
91
362
Inventory
39,179
34,054
Prepaid expenses and other current assets
15,844
8,557
Assets from discontinued operations, current
0
12,713
Total current assets
113,463
110,108
Non-current assets
Property and equipment, net
123,763
129,932
Deposits
0
60
Operating lease right of use assets
26,517
26,691
Intangible assets, net
175,337
167,310
Goodwill
113,892
109,770
Other non-current assets
733
13,508
Total non-current assets
440,242
447,271
Total assets
553,705
557,379
Current liabilities
Accounts payable and accrued liabilities
40,133
39,807
Deferred revenue
4,406
3,993
Convertible debt
0
10,355
Loans payable
14,049
5,322
Operating lease liability
1,119
1,511
Derivative liability
0
967
Corporate income tax payable
2,290
5,360
Liabilities from discontinued operations
0
12,616
Total current liabilities
61,997
79,931
Non-current liabilities
Loans payable
183,226
203,846
Operating lease liability
28,948
28,555
Derivative liability
14,688
2,221
Convertible debt
16,271
6,896
Deferred income tax liability
11,900
8,025
Liability on uncertain tax position
152,547
128,798
Other long-term liabilities
86
86
Total non-current liabilities
407,666
378,427
Total liabilities
469,663
458,358
Commitments and contingencies
Share capital
Common shares, no par value, unlimited shares authorized; 309,175,647 and 308,532,518 shares outstanding as of June 30, 2026 and December 31, 2025, respectively
0
0
Treasury stock, no par value; nil and nil shares outstanding as of June 30, 2026 and December 31, 2025, respectively
0
0
Additional paid in capital
959,974
960,241
Accumulated other comprehensive income
2,605
1,986
Accumulated deficit
(882,963)
(864,742)
Non-controlling interest
4,426
1,536
Total shareholders' equity
84,042
99,021
Total liabilities and shareholders' equity
553,705
557,379
Series A Convertible Preferred Stock
Share capital
Preferred stock
Series B Convertible Preferred Stock
Share capital
Preferred stock
Exchangeable Shares
Share capital
Preferred stock